AoPcasts: "The Consult" Bringing you the latest in medical research
Association of Physicians
5 episodes
1 day ago
Immune Mediated Inflammatory Diseases (IMIDs) are a common and growing problem. Traditional models of research and service delivery silo their management within specific specialities and within adult or paediatric settings. Very often patients with disease in one organ have co-morbid involvement in another, suggesting shared pathogenic pathways. Moreover, IMIDs are often treated in very similar ways (combination therapy) with very similar drugs (steroids and anti TNF biologics). In this semin...
All content for AoPcasts: "The Consult" Bringing you the latest in medical research is the property of Association of Physicians and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Immune Mediated Inflammatory Diseases (IMIDs) are a common and growing problem. Traditional models of research and service delivery silo their management within specific specialities and within adult or paediatric settings. Very often patients with disease in one organ have co-morbid involvement in another, suggesting shared pathogenic pathways. Moreover, IMIDs are often treated in very similar ways (combination therapy) with very similar drugs (steroids and anti TNF biologics). In this semin...
AoPcasts: "The Consult" Bringing you the latest in medical research
1 minute
4 years ago
INTRODUCTION: Introducing AoPcasts
Welcome to the Association of Physicians (AoP) podcast series AoPcasts: Bringing you the latest in medical research. The AoPcasts is a fascinating series of podcasts bringing cutting edge medical research to new audiences. Produced by the AoP and hosted by science broadcaster Vivienne Parry, the series will explore some of the major themes debated at the annual AoP meeting. The first AoPcast brings together Rino Rappuoli, Chief Scientist of the vaccines division of GSK an...
AoPcasts: "The Consult" Bringing you the latest in medical research
Immune Mediated Inflammatory Diseases (IMIDs) are a common and growing problem. Traditional models of research and service delivery silo their management within specific specialities and within adult or paediatric settings. Very often patients with disease in one organ have co-morbid involvement in another, suggesting shared pathogenic pathways. Moreover, IMIDs are often treated in very similar ways (combination therapy) with very similar drugs (steroids and anti TNF biologics). In this semin...
